NCT00447070
- Conditions
- Acquired Immunodeficiency Syndrome, Arterial Occlusive Diseases, Arteriosclerosis, +23 more
- Locations
-
- University Hospital Zurich, Infectiology Zurich, Canton of Zurich, Switzerland
Clinical trial condition
Dyslipidemia
Explore clinical trials studying Dyslipidemia. Study availability and eligibility vary by location and protocol.
393 public trials
29 recruiting studies
Dyslipidemia trial results
NCT00326326
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site Anniston, Alabama, United States
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Greenbrae, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00029835
- Conditions
- Body Weight, Dyslipidemia, Dyslipidemias, +9 more
- Locations
-
- Clinic of Physicians and Surgeons, LTD Mesa, Arizona, United States
- Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
- Irvine Center for Clinical Research (ICCR) Irvine, California, United States
- Los Angeles Clinical Trials Los Angeles, California, United States
NCT00239967
- Conditions
- Body Weight, Dyslipidemia, Dyslipidemias, +9 more
- Locations
-
- Sanofi-aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-aventis Administrative Office Macquarie Park, Australia
- Sanofi-aventis Administrative Office São Paulo, Brazil
- Sanofi-aventis Administrative Office Laval, Canada
NCT00240305
- Conditions
- Dyslipidemia, Dyslipidemias, Glucose Metabolism Disorders, +6 more
- Locations
-
- Research Site Perth, Western Australia, Australia
NCT00845637
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
Completed
Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests
NCT00108212
- Conditions
- Dyslipidemia, Dyslipidemias, Inflammation, +5 more
- Locations
-
- VA Maryland Health Care System Baltimore, Maryland, United States
Completed
Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
NCT00345410
- Conditions
- Body Weight, Dyslipidemia, Dyslipidemias, +9 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
NCT00593047
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Carl-Peter Anderberg Gothemburg, Sweden
NCT00194402
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Northwest Lipid Research Clinic, University of Washington Seattle, Washington, United States